Noxopharm, a clinical-stage Australian drug development company currently working with 乔治临床( George Clinical ), is seeking to establish Veyonda®, an innovative dosage formulation of the experi […]
了解更多
OneOncology, a national partnership of community oncologists, recently announced that Lee Schwartzberg, MD, FACP, a member of the 乔治临床( George Clinical ) scientific leadership committee, has b […]
了解更多
ISN World Congress of Nephrology will be live streaming “Late Breaking Clinical Trials” from WCN 2019. The purpose of the webcast is to give the worldwide nephrology community in-depth underst […]
了解更多乔治临床( George Clinical ), a global scientifically backed clinical research organization, (CRO) has expanded its footprint in Asia with the addition of a new presence in Singapore. The new offic […]
了解更多
OVERLAND PARK, KS, March 6, 2019 乔治临床( George Clinical ), a leading Asia-Pacific based clinical research organization (CRO) with global capabilities, today announced that Dr. Maria Ali has bee […]
了解更多[Sydney, Australia] 乔治临床( George Clinical ) congratulates its parent company, The George Institute for Global Health for securing $12 million from the National Health and Medical Research Coun […]
了解更多乔治临床( George Clinical ) congratulates its parent company, The George Institute for Global Health for securing a project grant that could transform the treatment of chronic kidney disease (CKD) […]
了解更多乔治临床( George Clinical ) welcomes the recognition of Professor Craig Anderson as profiled in the premier medical journal The Lancet which identified him as “a front runner in stroke resea […]
了解更多乔治临床( George Clinical ) welcomes the recent announcement by our partner organization, West Cancer Center of their intention to join OneOncology in January 2019. The announcement sees a departu […]
了解更多SYDNEY, January 22, 2019 – 乔治临床( George Clinical ), headquartered in Sydney, Australia, a global scientifically backed CRO, today announced the appointment of James Cheong to the role of Chief […]
了解更多
